Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00041548 · ClinicalTrials.gov registry record · Phase 1
Inhaled Nitric Oxide in Neonates With Elevated A-a DO2 Gradients Not Requiring Mechanical Ventilation
A Phase 1 study, sponsored by Mallinckrodt.
- Terminated
- Registry status
- Phase 1
- Development phase
- 7
- Enrollment target
NCT00041548 is a Phase 1 study that was terminated before completion, run by Mallinckrodt. The registered enrollment target is 7 participants.
The verdict
NCT00041548, a Phase 1 study, was terminated before completion, sponsored by Mallinckrodt.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 7 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to evaluate whether administration of nitric oxide (NO)gas by oxygen hood at 20 ppm significantly increases PaO2, as compared to placebo gas (oxygen), within one hour of initiation and with no significant adverse effects.
Interventions
- DRUG Oxygen
- DRUG nitric oxide for inhalation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2002-05 |
| Est. Completion | 2005-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00041548
The ClinicalTrials.gov registry entry for NCT00041548 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mallinckrodt, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Oxygen is the first listed.
NCT00041548 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00041548 about?
NCT00041548 is a clinical study titled "Inhaled Nitric Oxide in Neonates With Elevated A-a DO2 Gradients Not Requiring Mechanical Ventilation". The purpose of this pilot study is to evaluate whether administration of nitric oxide (NO)gas by oxygen hood at 20 ppm significantly increases PaO2, as compared to placebo gas (oxygen), within one hour of initiation and with no significant adverse effects.
What is the current status of trial NCT00041548?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 7 participants. The study started on 2002-05. Estimated completion is 2005-06.
What interventions are being tested in trial NCT00041548?
The interventions under investigation include: Oxygen (DRUG), nitric oxide for inhalation (DRUG).
Who is sponsoring clinical trial NCT00041548?
This trial is sponsored by Mallinckrodt, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.